Skip to content

Cognition in Postoperative Total Hip Arthroplasty and Total Hip Resurfacing Patients

Cognition in Postoperative Total Hip Arthroplasty and Total Hip Resurfacing Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01079468
Enrollment
100
Registered
2010-03-03
Start date
2010-01-31
Completion date
2011-11-30
Last updated
2011-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition

Keywords

Transient cognitive decline following orthopaedic surgery

Brief summary

Transient cognitive changes after surgery may be due to many different factors. It is estimated that between 5-29% of patients undergoing orthopedic surgery experience a transient decline in their cognition. Fat and bone marrow debris embolization can cause cognitive changes if they enter the cerebral circulation in significant numbers. During total hip arthroplasty the placement of the femoral stem leads to a rise in intramedullary pressure which can cause fat and bone marrow debris to embolize into the systemic circulation. Total hip resurfacing arthroplasty avoids entrance into the femoral canal. The purpose of this study is to assess transient cognitive changes after total hip arthroplasty and compare them to patients undergoing total hip resurfacing arthroplasty. We hypothesize that patients undergoing total hip resurfacing arthroplasty will experience less transient cognitive changes due to the avoidance of violating the femoral canal during the procedure.

Interventions

None listed

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male and non-pregnant, non-lactating, female subjects who are 18 and older 2. Subjects who are able and willing to provide informed consent 3. Subjects deemed able to comply with study schedule visits and procedures 4. Subjects undergoing elective THA procedures 5. Subjects undergoing elective total hip resurfacing arthroplasty 6. Subjects in satisfactory health as determined by the investigator on the basis of medical history and physical examination.

Exclusion criteria

1. Subjects with or with a history of Parkinson's Disease 2. Subjects with a history of depression as reported in their past medical history 3. Subjects with a history of dementia as reported in their past medical history 4. Subjects currently using antidepressants 5. Subjects currently using antipsychotic medications

Design outcomes

Primary

MeasureTime frame
Degree of transient cognitive changes postoperatively as measured by the Folstein mini-mental examination

Secondary

MeasureTime frame
Percentage of patient who experience transient cognitive decline following Total Hip Arthroplasty or total hip resurfacing arthroplasty as measured by the Folstein mini-mental examination

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026